Skip to content
(614)355-5560
November 17, 2023
Update: Nirsevimab 100 mg Syringe Shortage

Nirsevimab 100 mg syringe shortage has resulted in updated guidance from the Centers for Disease Control and Prevention (CDC) for how to prioritize nirsevimab administration. Per their guidance, 100 mg doses should be reserved for infants less than 6 months old and infants with underlying conditions that place them at highest risk for severe RSV disease.

Related Articles
Pharmacy Updates
June 3, 2024
Updated Attention Deficit Hyperactivity Disorder (ADHD) Guidelines Are Now Available
Resources within the guideline include screening tools, treatment algorithms, and medication dosing recommendations.
Read More
Pharmacy Updates
May 2, 2024
Over-the-Counter Preferred Drug List for Ohio Medicaid Plans
The Partners For Kids’ Pharmacy Team has created a list containing covered pediatric over-the-counter medications for patients insured by an Ohio Medicaid plan.
Read More
Pharmacy Updates
May 2, 2024
Over-the-Counter Preferred Drug List for Ohio Medicaid Plans
The Partners For Kids’ Pharmacy Team has created a list containing covered pediatric over-the-counter medications for patients insured by an Ohio Medicaid plan.
Read More
Pharmacy Updates
April 18, 2024
Updated: Urinary Tract Infections Prescribing Guidelines
Read More
Pharmacy Updates
April 3, 2024
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
April 3, 2024
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List (UPDL)
Read More